"The first quarter 2008 research and development expenses also included $5.1 million of expense related to the ATryn program, compared with $4.7 million in the first quarter of 2007. These expenses included cost to manufacture ATryn in excess of the maximum selling price to LEO..."
I am probably not reading this correctly; does the last line mean that manufacturing Atryn costs more than the selling price to LEO???
"While we had hoped to be able to complete this negotiation by this time, our potential partner had become diverted for a time by other corporate activities."